Stifel Financial Corp Acquires 13,239 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Stifel Financial Corp boosted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 14.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 106,313 shares of the company's stock after purchasing an additional 13,239 shares during the period. Stifel Financial Corp's holdings in Ryan Specialty were worth $6,821,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in RYAN. Raymond James Financial Inc. bought a new stake in Ryan Specialty in the fourth quarter worth about $94,484,000. Norges Bank bought a new stake in Ryan Specialty in the fourth quarter worth about $78,358,000. Principal Financial Group Inc. lifted its stake in Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after purchasing an additional 981,505 shares during the last quarter. CIBC Private Wealth Group LLC lifted its stake in Ryan Specialty by 6,911.0% in the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after purchasing an additional 774,718 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in Ryan Specialty by 5.7% in the fourth quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock worth $633,933,000 after purchasing an additional 529,631 shares during the last quarter. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Trading Up 0.6 %

Shares of RYAN stock opened at $65.24 on Tuesday. The stock has a 50 day simple moving average of $70.35 and a 200-day simple moving average of $68.88. Ryan Specialty Holdings, Inc. has a 1-year low of $48.67 and a 1-year high of $77.16. The company has a market cap of $17.09 billion, a price-to-earnings ratio of 94.55, a PEG ratio of 1.19 and a beta of 0.66. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The company had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. On average, equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio (DPR) is 69.57%.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the business's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total value of $2,061,686.76. Following the transaction, the director now owns 2,697 shares in the company, valued at approximately $177,031.08. This represents a 92.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Wall Street Analyst Weigh In

RYAN has been the topic of a number of research reports. Barclays reduced their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Royal Bank of Canada reduced their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Wells Fargo & Company reduced their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. TD Cowen initiated coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. Finally, UBS Group raised their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $75.67.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.